참고문헌
- Brodin L. H., Valind S-O., Rhodes C. G., PantinC. F., Sweatman M. and Jones T. Fluorine-ISdeoxyglucose uptake in sarcoidosis measured withpositron emission tomography. Eur J Nucl Med1994;21:297-305.
- Haberkorn U., Ziegler S. I., Oberdorfer F., TrojanH., Haag D., Peschke P., Berger M., Altmann A.and Kaick G. V. FDG uptake, tumor proliferationand expression of glycolysis associated genes inanimal tumor models. Nucl Med Bioi 1994;21:827-834.
- Reske S. N., Grillenberger K. G., Glatting G.,Port M., Hildebrandt M., Gansauge F. and BegerH-G. Over expression of glucose transporter 1and increased FDG uptake in pancreatic carcinoma.J Nucl Med 1997;38:1344-1348 .
- Wahl R. L., Henry C. A. and Ethier S. P. Serumglucose: Effects on tumor and normal tissueaccumulation of 2-[F-18]-fluoro-2-deoxy-D-glucosein rodents with mammary carcinoma. Radiology1992;183:643-647.
- Ichiya Y., Kuwabara Y., Sasaki M., Yoshida T., Omagari J., Akash Y., Kawashima A., Fukumura T. and Masuda K. FDG-PET in infectious lesions: the detection and assessment of lesion activity. Ann Nucl Med 1996;10:185-191.
- Fukuzumi M., Shinomiya H., Shimizu Y., OhishiK. and Utsumi S. Endotoxin-induced enhancementof glucose influx into murine peritonealmacrophages via GLUT 1. Infect Immunol1996;64:108-112.
- Gamelli RL., Liu H., He L.K. and HofmannC.A. Augmentation of glucose uptake andglucose transporter-I in macrophages followingthermal injury and sepsis in mice. J Leukoc Bioi1996;59:639-647.
- Kubota R., Yamada S., Kubota K., Ishiwata K.,Tarnahashi N. and Ido T. Intratumoral distributionof Flurine-18-fluorodeoxyglucose in vivo: highaccumulation in macrophages and granulationtissues studied by autoradiography. J Nucl Med1992;33: 1972-1980.
- Brown R S., Leung I. Y., Fisher S. I., Frey K.A., Ethier S. P. and Wahl R L. Intratumoraldistribution of tritiated-FDG in breast carcinoma:correlation between Glut-1 expression and FDGuptake. J Nucl Med 1996;37:1042-1047.
- Brown R S. and Wahl R. Overexpression ofGLUT 1 glucose transporter in human breastcancer. An immunohistochemical study. Cancer1993;72: 2979-2985.
- Bustamante E., Morris H. P. and Petersen P. L.Energy metabolism of tumor cells: Requirementfor a form of hexokinase with a propensity formitochondrial binding. J Bioi Chem 1981;256:8699-8704.
- Chung I-K., Lee Y. I., Kim c., Choi S. R, KimM., Lee K. L., Ieong J. M., Lee D. S., langI-I., and Lee M. C. Mechanisms related to[18F]fluorodeoxyglucose uptake of human coloncancers transplanted in nude mice. J Nucl Med1999;40:339-346.
- Monakhov N. K., Neistadt E. L. and Shavlovskii M. M. Physicochemical properties and isozyme composition of hexokinase from normal andmalignant human tissues. J Natl Cancer Inst 1978;61:27-34.
- Nisoka T., Oda Y., Seino Y., Yamamoto T.,Inagaki N., Yano H., Imura H., Shigemoto Rand Kikuchi H. Distribution of the glucosetransporters in human brain tumors. Cancer Res1992;52:3972-3979.
- Waki A., Kato H., Yano R., Sadato N.,Yokoyama A., Ishii Y., Yonekura Y. andFujibayashi A. The importance of glucosetransport activity as the rate-limiting step of2-deoxyglucose uptake in tumor cells in vivo.Nucl Med Bioi 1998;25:593-597.
- Mellanen P., Minn H. and Grenman RExpression of glucose transporters in head-andneck tumors. Int J Cancer 1992;56:622-629.
- Glick R., Unterman T. and Lacson RIdentification of insulin-like growth factor (lGF)and glucose transporter 1 and 3 mRNA in CNStumors. Regul Pept 1993;48:251-256.
- Grobholz R, Hacker H. and Thorens B.Reduction in the expression of glucosetransporter protein GLUT2 in preneoplastic andneoplastic lesions and reexpression of GLUTI inlate stages of hepatocarcinogenesis. Cancer Res1993;53:4204-4211.
- Yamamoto T., Seino Y., Fukumoto H., Koh G.,Yano H., Inagaki N., Yamada Y., Inoue K.,Manabe T. and Imura H. Over-expression offacilitative glucose transporter genes in humancancer. Biochem Biophy Res Comm 1990;170:223-230.
- Malide D., Davies-Hill T. M., Levine M. andSimpson 1. A. Distinct localization of GLUT-I,-3, and -5 in human monocyte-derivativemacrophages: effects of cell activation. Am JPhysiol 1998;74:E5l6-526.
- Flier J. S., Mueckler M., McCall A. L. and Lodish H. F. Distribution of glucose transporter messenger RNA transcripts in tissues in rat and man. J Clin Invest 1987;79:657-661.
- Torizuka T., Clavo A. C. and Whal R L. Invitro study of PET tumor tracers at normal andelevated media glucose levels. J Nucl MedSuppl 1996;37:64p.
- Parry D. M. and Pedersen P. L. Intracellularlocalization and properties of particulatehexokinase in the Novikoff ascites tumor:Evidence for an outer mitochondrial membranelocation, J Bioi Chem 1983;258:10904-10912.
- Gallagher B. M., Fowler J. S., Gutterson N. I.,McGregor R R, Wan C. N. and Wolf A. P.Metabolic trapping as a principle of radiopharmaceuticaldesign: Some factors responsible forthe biodistribution of [18F]2-deoxy-2-D-glucose.J NuclMed 1978;19:1154-1161.
- Barghouthi S., Everett K. D. E. and Speert D. P.Nonopsonic phagocytosis of Pseudomonasaeruginosa requires facilitated transport ofD-glucose by macrophages. J Immunol 1995;154:3420-3428.
- Asano T., Shibasaki Y., Lin J-J., Tsukuda K.,Katagiri H., Ishihara H., Yazaki Y. and Oka Y.Expression of GLUTl glucose transporterincreases thymidine uptake in Chinese hamsterovary cells at low glucose concentrations.Cancer Res 1991; 51:4450-4454.
- Haspel H. C., Wilk E. W., Birnbaum M. J.,Cusshman S. w., Rosen O. M Glucose deprivationand hexokinase transporter polypeptides ofmurine fibroblasts. J Biol Chem 1986;261:6778-6789.
- Hoh C., Schiepers C., Seltzer M. A., Gambhir S.S., Silverman D. H. S., Czemin 1., Maddahi J.and Phelps M.E. PET in oncology: will itreplace the other modalities? Semin Nucl Med1997;27:94-106.